Notebook

If you say something often enough, maybe people will listen. For the fifth time in the past four years, the National Institutes of Health is telling scientists conducting clinical research to include women in their study populations. This latest exhortation comes after Sen. Barbara Mikulski (D-Md.) and other members of the Congressional Caucus for Women's Issues, following up on a recent General Accounting Office report that pointed out NIH's dismal performance to date in this area, blasted NIH

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

If you say something often enough, maybe people will listen. For the fifth time in the past four years, the National Institutes of Health is telling scientists conducting clinical research to include women in their study populations. This latest exhortation comes after Sen. Barbara Mikulski (D-Md.) and other members of the Congressional Caucus for Women's Issues, following up on a recent General Accounting Office report that pointed out NIH's dismal performance to date in this area, blasted NIH and proposed legislation to address a range of women's health issues. The new NIH policy requires scientists seeking federal funding for clinical research to include women in proportion to the degree they are affected by the disease being studied. It goes into effect on applications submitted after Feb. 1, 1991. Failure to include an adequate number of females will result in a lower priority score from the study section reviewing the application. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies